Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Nycomed slashes jobs

April 9, 2007 | A version of this story appeared in Volume 85, Issue 15

Nycomed is cutting roughly 10% of its workforce, or 1,250 employees, following its acquisition of Altana Pharma. The goal is to improve efficiency and increase R&D productivity in preparation for generic competition to the ulcer medication Protonix, the company's best selling product. Protonix, which originated at Altana, is slated to lose patent protection in Europe in 2009 and in the U.S. in 2010. About 585 of the job cuts will come from the company's R&D organization. Altana's former headquarters in Konstanz, Germany, will be hit by 790 layoffs.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.